<DOC>
	<DOCNO>NCT03071965</DOCNO>
	<brief_summary>This study prospective , phase 2 extension study participant previously enrol NTMT-01 participant enrol NTMT-02 . This study design evaluate long term safety efficacy NT-501 implant participant previously enrol NTMT-01 NTMT-02 protocol .</brief_summary>
	<brief_title>Extension Study NT-501 Ciliary Neurotrophic Factor ( CNTF ) Implant Macular Telangiectasia ( MacTel )</brief_title>
	<detailed_description />
	<mesh_term>Telangiectasis</mesh_term>
	<criteria>Previously enrol NTMT01 NTMT02 protocol receive NT501 implant and/or underwent Sham procedure Participant must offer sufficient opportunity review understand inform consent form , agree form 's content , provide write informed consent . There Exclusion Criteria</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>